Wounds : a compendium of clinical research and practice · 2026
Hydrosurgical debridement system combined with negative pressure wound therapy for the treatment of large chronic wounds caused by polyacrylamide hydrogel injection for breast augmentation.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xu Xun, Wang Ruoyu, Wu Honglin, Xu Jinxiong, Miao Yulan
Аннотация
BACKGROUND: Polyacrylamide hydrogel (PAHG) is a synthetic, gelatinous chemical substance commonly used as an injectable filler in breast augmentation surgery. However, its decomposition within several years postoperative often leads to various complications, causing significant physical and psychological distress to patients. The key to treatment is thorough debridement and wound drainage. Traditional debridement methods have limitations, such as long duration, significant trauma, and incomplete debridement. A hydrosurgical debridement system offers a new approach to wound healing.
CASE REPORT: This report presents 2 cases in which a hydrosurgical debridement system combined with negative pressure wound therapy was used to treat large chronic wounds of the trunk, perineum, and lower limbs caused by PAHG injection for breast augmentation.
CONCLUSION: The hydrosurgical debridement system played a key role in the treatment of the 2 cases, resulting in a good prognosis and no recurrence at 12- to 18-month follow-up.
CASE REPORT: This report presents 2 cases in which a hydrosurgical debridement system combined with negative pressure wound therapy was used to treat large chronic wounds of the trunk, perineum, and lower limbs caused by PAHG injection for breast augmentation.
CONCLUSION: The hydrosurgical debridement system played a key role in the treatment of the 2 cases, resulting in a good prognosis and no recurrence at 12- to 18-month follow-up.